ClinicalTrials.Veeva

Menu

Oxygen Supplementation During Bronchoscopy: High Flow Versus Low Flow Oxygen

S

Shaare Zedek Medical Center

Status

Unknown

Conditions

Hypoxia

Treatments

Device: High flow nasal oxygen supplementation
Device: low flow nasal oxygen supplementation

Study type

Interventional

Funder types

Other

Identifiers

NCT02253706
HFO-Rx1

Details and patient eligibility

About

In general bronchoscopy is a safe procedure with low rate of complications. Indeed, contraindications to flexible bronchoscopy are mostly relative rather than absolute. This is the case of preexisting decreased blood oxygen levels which may be present in patients requiring further bronchopulmonary investigation. To avoid the deleterious effects of oxygen drops oxygen supplementation is recommended.

The purpose of this study is to evaluate the efficiency and safety of oxygen supplementation obtained with the use of a high flow nasal cannula compared with a low flow nasal cannula during flexible bronchoscopy.

Consecutive patients referred by their treating physician for bronchoscopy will be offered to take part in the study. Those who wish to participate and give their consent will be randomly assigned into one of two treatment groups (supplemental oxygen given via low flow nasal cannula or via high flow nasal cannula).

Assignment to either treatment arm will not affect in any way the intended purpose of the bronchoscopy. All patients will be closely monitored during the procedure and 2 hours following its completion. Monitoring will be conducted, using strictly non-invasive measures.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients scheduled to undergo routine bronchoscopy for diagnostic purposes

Exclusion criteria

  • inability to give an informed consent
  • nasal deformities

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Low flow nasal oxygen supplementation
Active Comparator group
Description:
Low flow nasal oxygen supplementation as per routine standard of care(control arm)
Treatment:
Device: low flow nasal oxygen supplementation
High flow nasal oxygen supplementation
Experimental group
Description:
High-flow nasal ventilation: This will be carried out using the Precision Flow device (Opti-Flow, Auckland, New Zealand). This device is intended to add warm moisture to breathing gases from an external source. Flow rate via the nasal cannula will be kept at 50 Liters/min and fractional inspired oxygen concentration will be set at 0.35
Treatment:
Device: High flow nasal oxygen supplementation

Trial contacts and locations

1

Loading...

Central trial contact

Ayal Romem, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems